Artificial intelligence-driven pharmacovigilance analysis of polypharmacy and adverse events in breast cancer survivors treated with antidepressants
Certain polypharmacy regimens with antidepressants in specific breast cancer survivor subgroups may lead to complex safety signals. Personalized risk evaluation and vigilant medication safety strategies are crucial for these distinct, non-representative patients.
Authors
- Yu Zhou (ORCID: https://orcid.org/0000-0003-1942-3073)
- M W Zhang
- Boya Gao
- Jianbin Li (ORCID: https://orcid.org/0000-0001-7813-0452)
- Heng Liu (ORCID: https://orcid.org/0000-0001-6683-1462)
- Chenghua Kong
- Hanyu Chen (ORCID: https://orcid.org/0000-0002-8460-552X)
- Ye Chen (ORCID: https://orcid.org/0009-0007-6024-6562)
Institutions
- Fujian Medical University (CN)
- Fuzhou Second Hospital (CN)
- Fuzhou Maternity and Child Health Care Hospital (CN)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1097/js9.0000000000003538
- Citations
- 2
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 2.61